Advertisement

Applied Microbiology and Biotechnology

, Volume 95, Issue 6, pp 1457–1468 | Cite as

Novel whole-cell biocatalysts with recombinant hydroxysteroid dehydrogenases for the asymmetric reduction of dehydrocholic acid

  • Michael Braun
  • Boqiao Sun
  • Bernd Anselment
  • Dirk Weuster-BotzEmail author
Biotechnological products and process engineering

Abstract

Ursodeoxycholic acid is an important pharmaceutical so far chemically synthesized from cholic acid. Various biocatalytic alternatives have already been discussed with hydroxysteroid dehydrogenases (HSDH) playing a crucial role. Several whole-cell biocatalysts based on a 7α-HSDH-knockout strain of Escherichia coli overexpressing a recently identified 7β-HSDH from Collinsella aerofaciens and a NAD(P)-bispecific formate dehydrogenase mutant from Mycobacterium vaccae for internal cofactor regeneration were designed and characterized. A strong pH dependence of the whole-cell bioreduction of dehydrocholic acid to 3,12-diketo-ursodeoxycholic acid was observed with the selected recombinant E. coli strain. In the optimal, slightly acidic pH range dehydrocholic acid is partly undissolved and forms a suspension in the aqueous solution. The batch process was optimized making use of a second-order polynomial to estimate conversion as function of initial pH, initial dehydrocholic acid concentration, and initial formate concentration. Complete conversion of 72 mM dehydrocholic acid was thus made possible at pH 6.4 in a whole-cell batch process within a process time of 1 h without cofactor addition. Finally, a NADH-dependent 3α-HSDH from Comamonas testosteroni was expressed additionally in the E. coli production strain overexpressing the 7β-HSDH and the NAD(P)-bispecific formate dehydrogenase mutant. It was shown that this novel whole-cell biocatalyst was able to convert 50 mM dehydrocholic acid directly to 12-keto-ursodeoxycholic acid with the formation of only small amounts of intermediate products. This approach may be an efficient process alternative which avoids the costly chemical epimerization at C-7 in the production of ursodeoxycholic acid.

Keywords

Biocatalysis Cofactor regeneration Hydroxysteroid dehydrogenase Ursodeoxycholic acid Response surface methodology 

Notes

Acknowledgments

This work was supported by the Bayerische Forschungsstiftung within the project “Enzyme Catalyzed Steroid Oxidation” (AZ-777-07) and the company PharmaZell GmbH, Raubling, Germany. The authors gratefully acknowledge the support of the TUM Graduate School at the Technische Universität München.

References

  1. Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G (1992) Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. Hepatol 16:707–714CrossRefGoogle Scholar
  2. Bortolini O, Medici A, Poli S (1997) Biotransformations on steroid nucleus of bile acids. Steroids 62:564–577CrossRefGoogle Scholar
  3. Braun M, Link H, Liu L, Schmid RD, Weuster-Botz D (2011) Biocatalytic process optimization based on mechanistic modeling of cholic acid oxidation with cofactor regeneration. Biotechnol Bioeng 108:1307–1317CrossRefGoogle Scholar
  4. Carballeira JD, Quezada MA, Hoyos P, Simeó Y, Hernaiz MJ, Alcantara AR, Sinisterra JV (2009) Microbial cells as catalysts for stereoselective red-ox reactions. Biotechnol Adv 27:686–714CrossRefGoogle Scholar
  5. Carrea G, Pilotti A, Riva S, Canzi E, Ferrari A (1992) Enzymatic synthesis of 12-ketoursodeoxycholic acid from dehydrocholic acid in a membrane reactor. Biotechnol Lett 14:1131–1134CrossRefGoogle Scholar
  6. Duetz WA, van Beilen JB, Witholt B (2001) Using proteins in their natural environment: potential and limitations of microbial whole-cell hydroxylations in applied biocatalysis. Curr Opin Biotechnol 12:419–425CrossRefGoogle Scholar
  7. Edenharder R, Pfützner A, Hammann R (1989a) Characterization of NAD-dependent 3 alpha- and 3 beta-hydroxysteroid dehydrogenase and of NADP-dependent 7 beta-hydroxysteroid dehydrogenase from Peptostreptococcus productus. Biochim Biophys Acta 1004:230–238CrossRefGoogle Scholar
  8. Edenharder R, Pfützner M, Hammann R (1989b) NADP-dependent 3 beta-, 7 alpha- and 7 beta-hydroxysteroid dehydrogenase activities from a lecithinase-lipase-negative Clostridium species 25.11.c. Biochim Biophys Acta 1002:37–44CrossRefGoogle Scholar
  9. Gleeson D, Ruppin DC, Saunders A, Murphy GM, Dowling RH (1990) Final outcome of ursodeoxycholic acid treatment in 126 patients with radiolucent gallstones. Q J Med 76:711–729Google Scholar
  10. Grimm C, Maser E, Möbus E, Klebe G, Reuter K, Ficner R (2000) The crystal structure of 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni shows a novel oligomerization pattern within the short chain dehydrogenase/reductase family. J Biol Chem 275:41333–41339CrossRefGoogle Scholar
  11. Hirano S, Masuda N (1982) Characterization of NADP-dependent 7 beta-hydroxysteroid dehydrogenases from Peptostreptococcus productus and Eubacterium aerofaciens. Appl Environ Microbiol 43:1057–1063Google Scholar
  12. Hofmann AF (1963) The preparation of chenodeoxycholic acid and its glycine and taurine conjugates. Acta Chem Scand 17:173–186CrossRefGoogle Scholar
  13. Hofmann AF, Sjövall J, Kurz G, Radominska A, Schteingart CD, Tint GS, Vlahcevic ZR, Setchell KD (1992) A proposed nomenclature for bile acids. J Lipid Res 33:599–604Google Scholar
  14. Hölsch K, Weuster-Botz D (2010) Enantioselective reduction of prochiral ketones by engineered bifunctional fusion proteins. Biotechnol Appl Biochem 56:131–140CrossRefGoogle Scholar
  15. Igimi H, Carey MC (1981) Cholesterol gallstone dissolution in bile: dissolution kinetics of crystalline (anhydrate and monohydrate) cholesterol with chenodeoxycholate, ursodeoxycholate, and their glycine and taurine conjugates. J Lipid Res 22:254–270Google Scholar
  16. Koeller KM, Wong CH (2001) Enzymes for chemical synthesis. Nature 409:232–240CrossRefGoogle Scholar
  17. Liu L, Aigner A, Schmid RD (2011) Identification, cloning, heterologous expression, and characterization of a NADPH-dependent 7β-hydroxysteroid dehydrogenase from Collinsella aerofaciens. Appl Microbiol Biotechnol 90:127–135CrossRefGoogle Scholar
  18. Macdonald IA, Meier EC, Mahony DE, Costain GA (1976) 3alpha-, 7alpha- and 12alpha-hydroxysteroid dehydrogenase activities from Clostridium perfringens. Biochim Biophys Acta 450:142–153CrossRefGoogle Scholar
  19. Macdonald IA, Rochon YP, Hutchison DM, Holdeman LV (1982) Formation of ursodeoxycholic acid from chenodeoxycholic acid by a 7 beta-hydroxysteroid dehydrogenase-elaborating Eubacterium aerofaciens strain cocultured with 7 alpha-hydroxysteroid dehydrogenase-elaborating organisms. Appl Environ Microbiol 44:1187–1195Google Scholar
  20. Maser E, Möbus E, Xiong G (2000) Functional expression, purification, and characterization of 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni. Biochem Biophys Res Commun 272:622–628CrossRefGoogle Scholar
  21. Medici A, Pedrini P, Bianchini E, Fantin G, Guerrini A, Natalini B, Pellicciari R (2002) 7alpha-OH epimerisation of bile acids via oxido-reduction with Xanthomonas maltophilia. Steroids 67:51–56CrossRefGoogle Scholar
  22. Möbus E, Maser E (1998) Molecular cloning, overexpression, and characterization of steroid-inducible 3alpha-hydroxysteroid dehydrogenase/carbonyl reductase from Comamonas testosteroni. A novel member of the short-chain dehydrogenase/reductase superfamily. J Biol Chem 273:30888–30896CrossRefGoogle Scholar
  23. Monti D, Ferrandi EE, Zanellato I, Hua L, Polentini F, Carrea G, Riva S (2009) One-pot multienzymatic synthesis of 12-ketoursodeoxycholic acid: subtle cofactor specificities rule the reaction equilibria of five biocatalysts working in a row. Adv Synth Catal 351:1303–1311CrossRefGoogle Scholar
  24. Pedrini P, Andreotti E, Guerrini A, Dean M, Fantin G, Giovannini PP (2006) Xanthomonas maltophilia CBS 897.97 as a source of new 7beta- and 7alpha-hydroxysteroid dehydrogenases and cholylglycine hydrolase: improved biotransformations of bile acids. Steroids 71:189–198CrossRefGoogle Scholar
  25. Ridlon JM, Kang DJ, Hylemon PB (2006) Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47:241–259CrossRefGoogle Scholar
  26. Sambrook J, Russell DW (2001) Molecular cloning: a laboratory manual, 3rd edn. Cold Spring Harbor Laboratory, New YorkGoogle Scholar
  27. Samuelsson B, Bergman S, Bak TA, Varde E, Westin G (1960) Preparation of ursodeoxycholic acid and 3alpha,7beta,12alpha-trihydroxycholanic acid. Bile acids and steroids 94. Acta Chem Scand 14:17–20CrossRefGoogle Scholar
  28. Sawada H, Kulprecha S, Nilubol N, Yoshida T, Kinoshita S, Taguchi H (1982) Microbial production of ursodeoxycholic acid from lithocholic acid by Fusarium equiseti M41. Appl Environ Microbiol 44:1249–1252Google Scholar
  29. Schmid A, Dordick JS, Hauer B, Kiener A, Wubbolts M, Witholt B (2001) Industrial biocatalysis today and tomorrow. Nature 409:258–268CrossRefGoogle Scholar
  30. Serov AE, Popova AS, Fedorchuk VV, Tishkov VI (2002) Engineering of coenzyme specificity of formate dehydrogenase from Saccharomyces cerevisiae. Biochem J 367:841–847CrossRefGoogle Scholar
  31. Skålhegg BA (1974) On the 3 alpha-hydroxysteroid dehydrogenase from Pseudomonas testosteroni. Purification and properties. Eur J Biochem 46:117–125CrossRefGoogle Scholar
  32. Skålhegg BA (1975) 3alpha-Hydroxysteroid dehydrogenase from Pseudomonas testosteroni: kinetic properties with NAD and its thionicotinamide analogue. Eur J Biochem 50:603–609CrossRefGoogle Scholar
  33. Sutherland JD, Macdonald IA (1982) The metabolism of primary, 7-oxo, and 7 beta-hydroxy bile acids by Clostridium absonum. J Lipid Res 23:726–732Google Scholar
  34. Sutherland JD, Macdonald IA, Forrest TP (1982) The enzymic and chemical synthesis of ursodeoxycholic and chenodeoxycholic acid from cholic acid. Prep Biochem 12:307–321CrossRefGoogle Scholar
  35. Tishkov VI, Galkin AG, Fedorchuk VV, Savitsky PA, Rojkova AM, Gieren H, Kula MR (1999) Pilot scale production and isolation of recombinant NAD+- and NADP+-specific formate dehydrogenases. Biotechnol Bioeng 64:187–193CrossRefGoogle Scholar
  36. Van der Donk WA, Zhao H (2003) Recent developments in pyridine nucleotide regeneration. Curr Opin Biotechnol 14:421–426CrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Michael Braun
    • 1
  • Boqiao Sun
    • 1
  • Bernd Anselment
    • 1
  • Dirk Weuster-Botz
    • 1
    Email author
  1. 1.Institute of Biochemical EngineeringTechnische Universität MünchenGarchingGermany

Personalised recommendations